- Record: House Floor
- Section type: Executive business
- Chamber: House
- Date: October 22, 2026
- Congress: 119th Congress
- Why this source matters: This section came from the House floor portion of the record.
- RIN: 1505-AC97
the Speaker's table and referred as follows:
EC-4893. A letter from the Senior Legal Advisor for
Regulatory Affairs, Department of the Treasury, transmitting
the Department's interim final rule — Forms and Procedures
for Review of State Certifications by the Stablecoin
Certification Review Committee [TREAS-DO-2026-0562] (RIN:
1505-AC97) received October 5, 2026, pursuant to 5 U.S.C.
801(a)(1)(A); Public Law 104-121, Sec. 251; (110 Stat. 868);
to the Committee on Financial Services.
EC-4894. A letter from the Secretary, Department of Energy,
transmitting a letter to submit proposed legislative changes
to amend Section 4203 of the Employee Retirement Income
Security Act (Public Law No. 93-406) at 29 U.S.C. Section
1383; to the Committee on Education and Workforce.
EC-4895. A letter from the Deputy General Counsel, Office
of Civil Rights, Department of Education, transmitting the
Department's final rule — Recodification of Title IX Rules
(RIN: 1870-AA26) received September 30, 2026, pursuant to 5
U.S.C. 801(a)(1)(A); Public Law 104-121, Sec. 251; (110 Stat.
868); to the Committee on Education and Workforce.
EC-4896. A letter from the Administrator, Wage and Hour
Division, Department of Labor, transmitting the Department's
final rule — Rescission of Coordinated Enforcement
Regulations (RIN: 1235-AA50) received September 16, 2026,
pursuant to 5 U.S.C. 801(a)(1)(A); Public Law 104-121, Sec.
251; (110 Stat. 868); to the Committee on Education and
Workforce.
EC-4897. A letter from the Acting Section Chief, Drug
Enforcement Administration, Department of Justice,
transmitting the Department's notice of proposed rulemaking
— Schedules of Controlled Substances: Placement of
Tianeptine in Schedule I [Docket No.: DEA1596] received
September 20, 2026, pursuant to 5 U.S.C. 801(a)(1)(A); Public
Law 104-121, Sec. 251; (110 Stat. 868); to the Committee on
Energy and Commerce.
EC-4898. A letter from the Acting Section Chief, Drug
Enforcement Administration, Department of Justice,
transmitting the Department's final rule — Specific Listing
for Hexahydrocannabinol, A Currently Controlled Schedule I
Substance [Docket No.: DEA-1632] received September 23, 2026,
pursuant to 5 U.S.C. 801(a)(1)(A); Public Law 104-121, Sec.
251; (110 Stat. 868); to the Committee on Energy and
Commerce.
EC-4899. A letter from the Acting Section Chief, Drug
Enforcement Administration, Department of Justice,
transmitting the Department's final rule — Schedules of
Controlled Substances: Placement of 4F-MDMB-BUTICA, ADB-4en-
PINACA, 5F-EDMB-PICA, and MMB-FUBICA in Schedule I [Docket
No.: DEA-1604] received September 23, 2026, pursuant to 5
U.S.C. 801(a)(1)(A); Public Law 104-121, Sec. 251; (110 Stat.
868); to the Committee on Energy and Commerce.
EC-4900. A letter from the Acting Section Chief, Drug
Enforcement Administration, Department of Justice,
transmitting the Department's proposed amendment — Schedules
of Controlled Substance: Temporary Placement of 7-
Hydroxymitragynine Above a Specified Threshold in Schedule I
[Docket
No.: DEA-1570] received September 23, 2206, pursuant to 5
U.S.C. 801(a)(1)(A); Public Law 104-121, Sec. 251; (110 Stat.
868); to the Committee on Energy and Commerce.
EC-4901. A letter from the Acting Section Chief, Drug
Enforcement Administration, Department of Justice,
transmitting the Department's final rule — Schedules of
Controlled Substances: Placement of CUMYL-PEGACLONE in
Schedule I [Docket No.: DEA-1511] received September 23,
2026, pursuant to 5 U.S.C. 801(a)(1)(A); Public Law 104-121,
Sec. 251; (110 Stat. 868); to the Committee on Energy and
Commerce.
EC-4902. A letter from the Acting Section Chief, Drug
Enforcement Administration, Department of Justice,
transmitting the Department's final rule — Schedules of
Controlled Substances: Temporary Placement of 2-
Fluorodeschloroketamine in Schedule I [Docket No.: DEA-1442]
received September 23, 2026, pursuant to 5 U.S.C.
801(a)(1)(A); Public Law 104-121, Sec. 251; (110 Stat. 868);
to the Committee on Energy and Commerce.
EC-4903. A letter from the Acting Section Chief, Drug
Enforcement Administration, Department of Justice,
transmitting the Department's notice of proposed rulemaking
— Amendment to 3,4-MDP-2-P Methyl Glycidic Acid, a List I
Chemical [Docket No.: DEA-1427] received September 23, 2026,
pursuant to 5 U.S.C. 801(a)(1)(A); Public Law 104-121, Sec.
251; (110 Stat. 868); to the Committee on Energy and
Commerce.
EC-4904. A letter from the Acting Section Chief, Drug
Enforcement Administration, Department of Justice,
transmitting the Department's temporary amendment —
Schedules of Controlled Substances: Temporary Placement of
Mitragynine Pseudoindoxyl, MGM-15, and MGM-16 in Schedule I
[Docket No.: DEA-1644] received September 23, 2026, pursuant
to 5 U.S.C. 801(a)(1)(A); Public Law 104-121, Sec. 251; (110
Stat. 868); to the Committee on Energy and Commerce.
EC-4905. A letter from the Acting Section Chief, Drug
Enforcement Administration, Department of Justice,
transmitting the Department's final rule — Designation of
P2P Methyl Glycidic Acid as a List I Chemical [Docket No.:
DEA-1395] received September 23, 2026, pursuant to 5 U.S.C.
801(a)(1)(A); Public Law 104-121, Sec. 251; (110 Stat. 868);
to the Committee on Energy and Commerce.
EC-4906. A letter from the Acting Section Chief, Drug
Enforcement Administration, Department of Justice,
transmitting the Department's final rule — Schedules of
Controlled Substances: Placement of MDMB-4en-PINACA in
Schedule I [Docket No.: DEA-1356] received September 23,
2026, pursuant to 5 U.S.C. 801(a)(1)(A); Public Law 104-121,
Sec. 251; (110 Stat. 868); to the Committee on Energy and
Commerce.
EC-4907. A letter from the Acting Section Chief, Drug
Enforcement Administration, Department of Justice,
transmitting the Department's final amendment — Schedules of
Controlled Substances: Placement of N-Pyrrolidino
Metonitazene and N-Pyrrolidino Protonitazene in Schedule I
[Docket No.: DEA-1337] received September 23, 2026, pursuant
to 5 U.S.C. 801(a)(1)(A); Public Law 104-121, Sec. 251; (110
Stat. 868); to the Committee on Energy and Commerce.
EC-4908. A letter from the Acting Section Chief, Drug
Enforcement Administration, Department of Justice,
transmitting the Department's notice of proposed rulemaking
— Designation of Phenethyl Halides as List I Chemicals
[Docket No.: DEA-1282] received September 23, 2026, pursuant
to 5 U.S.C. 801(a)(1)(A); Public Law 104-121, Sec. 251; (110
Stat. 868); to the Committee on Energy and Commerce.
EC-4909. A letter from the Acting Section Chief, Drug
Enforcement Administration, Department of Justice,
transmitting the Department's notice of proposed rulemaking
— Revision of Applications for Manufacturing and Procurement
Quotas [Docket No.: DEA-1278] (RIN: 1117-AB86) received
September 23, 2026, pursuant to 5 U.S.C. 801(a)(1)(A); Public
Law 104-121, Sec. 251; (110 Stat. 868); to the Committee on
Energy and Commerce.
EC-4910. A letter from the Acting Section Chief, Drug
Enforcement Administration, Department of Justice,
transmitting the Department's proposed amendment — Schedules
of Controlled Substances: Temporary Placement of 5,6-Dichloro
Brorphine, 5,6-Dichloro Desmethylchlorphine, N-Propionitrile
Chlorphine, and Spirochlorphine in Schedule I of the
Controlled Substances Act [Docket No.: DEA-1665] received
September 23, 2026, pursuant to 5 U.S.C. 801(a)(1)(A); Public
Law 104-121, Sec. 251; (110 Stat. 868); to the Committee on
Energy and Commerce.
EC-4911. A letter from the Acting Section Chief, Drug
Enforcement Administration, Department of Justice,
transmitting the Department's notice of proposed rulemaking
— Schedules of Controlled Substances: Rescheduling of
Suvorexant, Lemborexant, and Daridorexant From Schedule IV
Into Schedule V [Docket No.: DEA-1645] received September 23,
2026, pursuant to 5 U.S.C. 801(a)(1)(A); Public Law 104-121,
Sec. 251; (110 Stat. 868); to the Committee on Energy and
Commerce.
EC-4912. A letter from the Deputy Assistant Administrator,
Drug Enforcement Administration, Department of Justice,
transmitting the Department's temporary amendment —
Schedules of Controlled Substances: Temporary Placement of
Mitragynine Pseudoindoxyl, MGM-15, and MGM-16 in Schedule I
[Docket No.: DEA-1644] received September 23, 2026, pursuant
to 5 U.S.C. 801(a)(1)(A); Public Law 104-121, Sec. 251; (110
Stat. 868); to the Committee on Energy and Commerce.
EC-4913. A letter from the Deputy Assistant Administrator,
Drug Enforcement Administration, Department of Justice,
transmitting the Department's proposed amendment — Schedules
of Controlled Substances: Temporary Placement of Mitragynine
Pseudoindoxyl, MGM-15, and MGM-16 in Schedule I [Docket No.:
DEA-1644] received September 23, 2026, pursuant to 5 U.S.C.
801(a)(1)(A); Public Law 104-121, Sec. 251; (110 Stat. 868);
to the Committee on Energy and Commerce.
EC-4914. A letter from the Acting Section Chief, Drug
Enforcement Administration, Department of Justice,
transmitting the Department's proposed amendment — Schedules
of Controlled Substances: Temporary Placement of O-
Desmethyltramadol in Schedule I [Docket No.: DEA-1641]
received September 23, 2026, pursuant to 5 U.S.C.
801(a)(1)(A); Public Law 104-121, Sec. 251; (110 Stat. 868);
to the Committee on Energy and Commerce.
EC-4915. A letter from the Acting Branch Chief, Regulatory
Management Branch, Environmental Protection Agency,
transmitting the Agency's final rule — Attainment Date
Extension for the South Coast, California 2012 Annual PM2.5
Fine Particulate Matter Nonattainment Area [EPA-R09-OAR-2026-
3664; FRL-13379-02-R9] received October 1, 2026, pursuant to
5 U.S.C. 801(a)(1)(A); Public Law 104-121, Sec. 251; (110
Stat. 868); to the Committee on Energy and Commerce.
EC-4916. A letter from the Acting Branch Chief, Regulatory
Management Branch, Environmental Protection Agency,
transmitting the Agency's final rule — Air Plan Approval;
Missouri; Control of NOx Emissions From Large Stationary
Internal Combustion Engines [EPA-R07-OAR-2026-4819; FRL-
13460-02-R7] received October 1, 2026, pursuant to 5 U.S.C.
801(a)(1)(A); Public Law 104-121, Sec. 251; (110 Stat. 868);
to the Committee on Energy and Commerce.
EC-4917. A letter from the Acting Branch Chief, Regulatory
Management Branch, Environmental Protection Agency,
transmitting the Agency's final rule — Phosphatidylcholine
in Pesticide Formulations; Exemption from the Requirement for
a Tolerance [EPA-HQ-OPP-2025-0090; FRL-13583-01-OCSPP]
received October 1, 2026, pursuant to 5 U.S.C. 801(a)(1)(A);
Public Law 104-121, Sec. 251; (110 Stat. 868); to the
Committee on Energy and Commerce.
EC-4918. A letter from the Assistant Secretary Bureau of
Legislative Affairs, Department of State, transmitting the
Department's final rule — International Traffic in Arms
Regulations: Syria Country Policy Revision [Public Notice:
13131] (RIN: 1400-AG38) received October 5, 2026, pursuant to
5 U.S.C. 801(a)(1)(A); Public Law 104-121, Sec. 251; (110
Stat. 868); to the Committee on Foreign Affairs.
EC-4919. A letter from the Chairman, Council of the
District of Columbia, transmitting DC Act 26-425, “Fiscal
Year 2026 Revised Local Budget Adjustment Temporary Act of
2026”, pursuant to Public Law 93-198, Sec. 602(c)(1); (87
Stat. 813); to the Committee on Oversight and Government
Reform.
EC-4920. A letter from the Chairman, Council of the
District of Columbia, transmitting DC Act 26-426, “Language
Access Rulemaking Authority Temporary Amendment Act of
2026”, pursuant to Public Law 93-198, Sec. 602(c)(1); (87
Stat. 813); to the Committee on Oversight and Government
Reform.
EC-4921. A letter from the Chairman, Council of the
District of Columbia, transmitting DC Act 26-427, “Health
and Human Service Programs and Benefits Eligibility and
Delivery Data-Sharing Clarifications Temporary Amendment Act
of 2026”, pursuant to Public Law 93-198, Sec. 602(c)(1); (87
Stat. 813); to the Committee on Oversight and Government
Reform.
EC-4922. A letter from the Chairman, Council of the
District of Columbia, transmitting DC Act 26-428, “Omnibus
Barry Farm Redevelopment Clarification Temporary Amendment
Act of 2026”, pursuant to Public Law 93-198, Sec. 602(c)(1);
(87 Stat. 813); to the Committee on Oversight and Government
Reform.
EC-4923. A letter from the Chairman, Council of the
District of Columbia, transmitting DC Act 26-429,
“Restoration of Covenanted Roads and Alleys by the District
Government Clarification Temporary Amendment Act of 2026”,
pursuant to Public Law 93-198, Sec. 602(c)(1); (87 Stat.
813); to the Committee on Oversight and Government Reform.
EC-4924. A letter from the Chairman, Council of the
District of Columbia, transmitting DC Act 26-430, “Net Zero
Continuity Temporary Amendment Act of 2026”, pursuant to
Public Law 93-198, Sec. 602(c)(1); (87 Stat. 813); to the
Committee on Oversight and Government Reform.
EC-4925. A letter from the Chairman, Council of the
District of Columbia, transmitting DC Act 26-433, “Private
Vehicle-for-Hire Operator Clarification Temporary Amendment
Act of 2026”, pursuant to Public Law 93-198, Sec. 602(c)(1);
(87 Stat. 813); to the Committee on Oversight and Government
Reform.
EC-4926. A letter from the Chairman, Council of the
District of Columbia, transmitting DC Act 26-420,
“Micromobility Fire Safety Standards Amendment Act of
2026”, pursuant to Public Law 93-198, Sec. 602(c)(1); (87
Stat. 813); to the Committee on Oversight and Government
Reform.
EC-4927. A letter from the Chairman, Council of the
District of Columbia, transmitting DC Act 26-421, “Personal
Delivery Device Weight Limit Amendment Act of
2026”, pursuant to Public Law 93-198, Sec. 602(c)(1); (87
Stat. 813); to the Committee on Oversight and Government
Reform.
EC-4928. A letter from the Chairman, Council of the
District of Columbia, transmitting DC Act 26-422,
“Posthumous Care Modernization Amendment Act of 2026”,
pursuant to Public Law 93-198, Sec. 602(c)(1); (87 Stat.
813); to the Committee on Oversight and Government Reform.
EC-4929. A letter from the Chairman, Council of the
District of Columbia, transmitting DC Act 26-423,
“Washington Commanders Motor Vehicle Identification Tags
Amendment Act of 2026”, pursuant to Public Law 93-198, Sec.
602(c)(1); (87 Stat. 813); to the Committee on Oversight and
Government Reform.
EC-4930. A letter from the Chairman, Council of the
District of Columbia, transmitting DC Act 26-424,
“Commercial Driver's License Amendment Act of 2026”,
pursuant to Public Law 93-198, Sec. 602(c)(1); (87 Stat.
813); to the Committee on Oversight and Government Reform.
EC-4931. A letter from the Chairman, Council of the
District of Columbia, transmitting DC Act 26-434, “Funeral
Services Modernization Amendment Act of 2026”, pursuant to
Public Law 93-198, Sec. 602(c)(1); (87 Stat. 813); to the
Committee on Oversight and Government Reform.
EC-4932. A letter from the Solicitor General, Office of the
Solicitor General, Department of Justice, transmitting a
determination in the case: Silencer Shop Foundation v. ATF,
No. 25-cv-056(N.D. Tex.), pursuant to 28 U.S.C. 530D(a)(1);
Public Law 107-273, Sec. 202(a); (116 Stat. 1771); to the
Committee on the Judiciary.
EC-4933. A letter from the Solicitor General, Office of the
Solicitor General, Department of Justice, transmitting a
determination in these cases: United States v. Martin, No.
25-30712 (5th Cir.) and United States v. Banuelos, No. 23-
50731 (5th Cir.), pursuant to 28 U.S.C. 530D(a)(1); Public
Law 107-273, Sec. 202(a); (116 Stat. 1771); to the Committee
on the Judiciary.
EC-4934. A letter from the Chief, Office of Regulatory
Affairs, Bureau of Alcohol, Tobacco, Firearms, and
Explosives, Department of Justice, transmitting the
Department's final rule — Annual Notices on Explosive
Materials Storage Facilities to Local Fire Authority [Docket
No.: ATF-2023-0001; ATF 2013R-15P] (RIN: 1140-AA51) received
September 29, 2026, pursuant to 5 U.S.C. 801(a)(1)(A); Public
Law 104-121, Sec. 251; (110 Stat. 868); to the Committee on
the Judiciary.
EC-4935. A letter from the Chief, Office of Regulatory
Affairs, Bureau of Alcohol, Tobacco, Firearms, and
Explosives, Department of Justice, transmitting the
Department's final rule — Implementing the Safe Explosives
Act [ATT No.: 2002R-341F] (RIN: 1140-AA00 and 1140-AA20)
received September 29, 2026, pursuant to 5 U.S.C.
801(a)(1)(A); Public Law 104-121, Sec. 251; (110 Stat. 868);
to the Committee on the Judiciary.
EC-4936. A letter from the Chief Regulatory Officer, USCIS,
Department of Homeland Security, transmitting the
Department's final rule — U.S. Citizenship and Immigration
Services Employment-Based Immigrant Visa, Fifth Preference
(EB-5) Fee Rule [CIS No.: 2846-26; DHS Docket No.: USCIS-
2025-0139] (RIN: 1615-AC93) received September 30, 2026,
pursuant to 5 U.S.C. 801(a)(1)(A); Public Law 104-121, Sec.
251; (110 Stat. 868); to the Committee on the Judiciary.
EC-4937. A letter from the Section Chief, Internal Revenue
Service, transmitting the Service's IRB only rule — Guidance
and Other Actions Being Considered Regarding Certain
Potentially Abusive Investment Fund Strategies Involving
Financial Products [Notice 2026-62] received October 5, 2026,
pursuant to 5 U.S.C. 801(a)(1)(A); Public Law 104-121, Sec.
251; (110 Stat. 868); to the Committee on Ways and Means.